Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MYCB1-BDR
- Development stage
- Unknown
- Lead developer
- MYCB1
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
MYCB1-BDR is a line of standardized, medical-grade cannabis oil solutions developed and manufactured by MYCB1. Produced under EU-GMP standards using raw materials from Bedrocan, these formulations are standardized to specific ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD) (such as MYCB1-BDR 25:1, 50:1, and 100:1). They are prescribed for various indications where medical cannabis is authorized, such as chronic pain, spasticity, and palliative care. The products are integrated with MYCB1's ALETTA platform to collect real-world evidence on patient outcomes and side effects.
- Brand names
- MYCB1-BDRMYCB-1-BDRMYCB 1-BDRMYCB1-BDR 100:1MYCB1-BDR 25:1MYCB1-BDR 50:1
- Other names
- MYCB1 BDRMYCB-1 BDRMYCB 1 BDRÖlige Cannabisharzöl-Lösung MYCB1-BDR
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MYCB1-BDR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MYCB1-BDR.